Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoes

International Journal for Parasitology

Volumn 43, Issue 11, 2013, Pages 869-874

  Williams, Andrew R ^a   Zakutansky, Sara E ^a   Miura, Kazutoyo ^b   Dicks, Matthew D J ^a   Churcher, Thomas S ^c   Jewell, Kerry E ^a   Vaughan, Aisling M ^a   Turner, Alison V ^a   Kapulu, Melissa C ^a   Michel, Kristin ^d   Long, Carole A ^b   Sinden, Robert E ^a,c   Hill, Adrian V S ^a   Draper, Simon J ^a   Biswas, Sumi ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d KANSAS STATE UNIVERSITY   (United States)

Author keywords

Antibodies; Malaria; Mosquito; Serpins; Vaccine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; SERINE PROTEINASE INHIBITOR; SERPIN 2; UNCLASSIFIED DRUG;

ANTIBODY; DISEASE TRANSMISSION; ENZYME; IMMUNE RESPONSE; IMMUNIZATION; INFECTIOUS DISEASE; INHIBITOR; MALARIA; MOSQUITO; PARASITE; VACCINE;

ANIMAL EXPERIMENT; ANOPHELES GAMBIAE; ANOPHELES STEPHENSI; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; GAMETOCYTE; INNATE IMMUNITY; MOUSE; NONHUMAN; OOCYST; PARASITE LOAD; PARASITE PREVALENCE; PARASITE TRANSMISSION; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PLASMODIUM FALCIPARUM;

ANOPHELES GAMBIAE; ANOPHELES STEPHENSI; MUS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM PARASITES;

ANTIBODIES; MALARIA; MOSQUITO; SERPINS; VACCINE;

ANIMALS; ANOPHELES; IMMUNITY, INNATE; INSECT PROTEINS; MICE; PLASMODIUM BERGHEI; SERPINS;

EID: 84883249591     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2013.06.004     Document Type: Article

References (26)

1. Alavi Y., Arai M., Mendoza J., Tufet-Bayona M., Sinha R., Fowler K., Billker O., Franke-Fayard B., Janse C.J., Waters A., Sinden R.E. The dynamics of interactions between Plasmodium and the mosquito: a study of the infectivity of Plasmodium berghei and Plasmodium gallinaceum, and their transmission by Anopheles stephensi, Anopheles gambiae and Aedes aegypti. Int. J. Parasitol. 2003, 33:933-943.
2. An C., Budd A., Kanost M., Michel K. Characterization of a regulatory unit that controls melanization and affects longevity of mosquitoes. Cell. Mol. Life Sci. 2011, 68:1929-1939.
3. Blagborough A.M., Sinden R.E. Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro. Vaccine 2009, 27:5187-5194.
4. Blandin S., Shiao S.-H., Moita L.F., Janse C.J., Waters A.P., Kafatos F.C., Levashina E.A. Complement-like protein TEP1 Is a determinant of vectorial capacity in the malaria vector Anopheles gambiae. Cell 2004, 116:661-670.
5. Cheru L., Wu Y., Diouf A., Moretz S.E., Muratova O.V., Song G., Fay M.P., Miller L.H., Long C.A., Miura K. The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species. Vaccine 2010, 28:4423-4429.
6. Churcher T.S., Blagborough A.M., Delves M., Ramakrishnan C., Kapulu M.C., Williams A.R., Biswas S., Da D.F., Cohuet A., Sinden R.E. Measuring the blockade of malaria transmission - an analysis of the standard membrane feeding assay. Int. J. Parasitol. 2012, 42:1037-1044.
7. Dinglasan R.R., Kalume D.E., Kanzok S.M., Ghosh A.K., Muratova O., Pandey A., Jacobs-Lorena M. Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen. PNAS 2007, 104:13461-13466.
8. Dong Y., Aguilar R., Xi Z., Warr E., Mongin E., Dimopoulos G. Anopheles gambiae immune responses to human and rodent Plasmodium parasite species. PLoS Pathog. 2006, 2:e52.
9. Dong Y., Das S., Cirimotich C., Souza-Neto J.A., McLean K.J., Dimopoulos G. Engineered Anopheles immunity to Plasmodium infection. PLoS Pathog. 2011, 7:e1002458.
10. Dong Y., Manfredini F., Dimopoulos G. Implication of the mosquito midgut microbiota in the defense against malaria parasites. PLoS Pathog. 2009, 5:e1000423.
11. Douglas A.D., Williams A.R., Illingworth J.J., Kamuyu G., Biswas S., Goodman A.L., Wyllie D.H., Crosnier C., Miura K., Wright G.J., Long C.A., Osier F.H., Marsh K., Turner A.V., Hill A.V., Draper S.J. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat. Commun. 2011, 2:601.
12. Draper S.J., Biswas S., Spencer A.J., Remarque E.J., Capone S., Naddeo M., Dicks M.D.J., Faber B.W., de Cassan S.C., Folgori A., Nicosia A., Gilbert S.C., Hill A.V.S. Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines. J. Immunol. 2010, 185:7583-7595.
13. Draper S.J., Moore A.C., Goodman A.L., Long C.A., Holder A.A., Gilbert S.C., Hill F., Hill A.V. Effective induction of high-titer antibodies by viral vector vaccines. Nat. Med. 2008, 14:819-821.
14. Goodman A.L., Blagborough A.M., Biswas S., Wu Y., Hill A.V., Sinden R.E., Draper S.J. A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity. PLoS ONE 2011, 6:e29428.
15. Kumar S., Molina-Cruz A., Gupta L., Rodrigues J., Barillas-Mury C. A peroxidase/dual oxidase system modulates midgut epithelial immunity in Anopheles gambiae. Science 2010, 327:1644-1648.
16. Lavazec C., Boudin C., Lacroix R., Bonnet S., Diop A., Thiberge S., Boisson B., Tahar R., Bourgouin C. Carboxypeptidases B of Anopheles gambiae as targets for a Plasmodium falciparum transmission-blocking vaccine. Infect. Immun. 2007, 75:1635-1642.
17. Ligoxygakis P., Pelte N., Ji C., Leclerc V., Duvic B., Belvin M., Jiang H., Hoffmann J.A., Reichhart J.-M. A serpin mutant links Toll activation to melanization in the host defence of Drosophila. EMBO J. 2002, 21:6330-6337.
18. Michel K., Budd A., Pinto S., Gibson T.J., Kafatos F.C. Anopheles gambiae SRPN2 facilitates midgut invasion by the malaria parasite Plasmodium berghei. EMBO Rep. 2005, 6:891-897.
19. Michel K., Suwanchaichinda C., Morlais I., Lambrechts L., Cohuet A., Awono-Ambene P.H., Simard F., Fontenille D., Kanost M.R., Kafatos F.C. Increased melanizing activity in Anopheles gambiae does not affect development of Plasmodium falciparum. PNAS 2006, 103:16858-16863.
20. Miura K., Keister D., Muratova O., Sattabongkot J., Long C., Saul A. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer. Malar. J. 2007, 6:107.
21. Murray C.J.L., Rosenfeld L.C., Lim S.S., Andrews K.G., Foreman K.J., Haring D., Fullman N., Naghavi M., Lozano R., Lopez A.D. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379:413-431.
22. Rodrigues J., Oliveira G.A., Kotsyfakis M., Dixit R., Molina-Cruz A., Jochim R., Barillas-Mury C. An epithelial serine protease, AgESP, is required for Plasmodium invasion in the mosquito Anopheles gambiae. PLoS ONE 2012, 7:e35210.
23. Rosenberg R. Malaria: some considerations regarding parasite productivity. Trends Parasitol. 2008, 24:487-491.
24. Sheehy S.H., Duncan C.J.A., Elias S.C., Choudhary P., Biswas S., Halstead F.D., Collins K.A., Edwards N.J., Douglas A.D., Anagnostou N.A., Ewer K.J., Havelock T., Mahungu T., Bliss C.M., Miura K., Poulton I.D., Lillie P.J., Antrobus R.D., Berrie E., Moyle S., Gantlett K., Colloca S., Cortese R., Long C.A., Sinden R.E., Gilbert S.C., Lawrie A.M., Doherty T., Faust S.N., Nicosia A., Hill A.V.S., Draper S.J. ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. Mol. Ther. 2012, 20:2355-2368.
25. Sinden R. A biologist's perspective on malaria vaccine development. Hum. Vaccines 2010, 6:3-11.
26. The malERA Consultative Group on Vaccines, 2011. A Research Agenda for Malaria Eradication: Vaccines, PLoS Med. Public Library of Science p. e1000398.